PFKFB3 and neoplasm: Consistently, treatment with a high dose of the PFKFB3 blocker 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) suppresses tumor EC proliferation and promotes EC death, ultimately causing tumor vessel disintegration (57).